Bio Gate AG Stock Xetra
Equities
DE000BGAG981
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
2023 | Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants | CI |
Sales 2023 * | 7M 7.51M | Sales 2024 * | 8.21M 8.81M | Capitalization | 9.24M 9.91M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 1.32 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.13 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 48.3% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Lloret-Grau
CEO | Chief Executive Officer | - | 12-01-07 |
Thomas Konradt
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Volker Rofalski
BRD | Director/Board Member | 54 | 11-12-31 |
Karl Richter
CHM | Chairman | - | - |
Volker Alt
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-2.92% | 185B | |
-3.80% | 105B | |
-5.48% | 66.59B | |
+11.22% | 54.66B | |
+16.74% | 47.78B | |
+4.06% | 41.26B | |
+4.56% | 26.95B | |
+1.64% | 26.37B | |
+12.96% | 24.8B |